Back to Department of Radiation Oncology
It's All Translational
That conviction drives the research in our Cancer Biology, Molecular Imaging and Physics Divisions as well as in the Clinical Division where the most obvious translation occurs.
Our scientists believe that their work in genomics or metabolomics or cancer cell biology is as much about improving cancer therapy as are quality of life studies and testing of new combination therapies or novel agents. Our physicists have been and continue to be leaders in the development of various imaging techniques to advance treatment planning and ever more precise delivery radiation therapy.
Department News
Arvind Rao, Ph.D., an associate professor in the departments of Computational Medicine and Bioinformatics (DCMB), Radiation Oncology and Biostatics, was selected to receive a Global REACH Partnership Development grant. His proposal is titled: “Towards development of a collaborative partnership for biomedical data science training and research between CSIR India and University of Michigan India platform.”
News Release
The 2024-25 Doximity Residency Navigator has been released. It shows that U-M has six top 5 medical education programs, with nine more in the top 10 and another nine in the top 25.
Health Lab
Researchers at the University of Michigan Health Rogel Cancer Center are one step closer to understanding how pediatric DIPG tumors work.
Health Lab
Experts in brain cancer outline current discoveries and offer a path of hope for glioblastoma treatment
Health Lab
At-home test can detect tumor DNA fragments in urine samples, providing a non-invasive alternative to traditional blood-based biomarker tests
Health Lab
Using a chip to process blood samples, doctors can monitor the amount of cancer cells in a patient’s blood to determine how well a treatment is working by the fourth week, according to a new study.
